The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
Open accessAbstract
BET bromodomain antagonist JQ1 reactivates HIV-1, while suppressing T cell activation genes, and upregulating histone modification genes that favor increased Tat activity. The persistence of latent HIV-1 remains a major challenge in therapeutic efforts to eradicate infection. We report the capacity for HIV reactivation by a selective small molecule inhibitor of BET family bromodomains, JQ1, a promising therapeutic agent with antioncogenic properties. JQ1 reactivated HIV transcription in models of latent T cell infection and latent monocyte infection. We also tested the effect of exposure to JQ1 to allow recovery of replication-competent HIV from pools of resting CD4+ T cells isolated from HIV-infected, ART-treated patients. In one of three patients, JQ1 allowed recovery of virus at a frequency above unstimulated conditions. JQ1 potently suppressed T cell proliferation with minimal cytotoxic effect. Transcriptional profiling of T cells with JQ1 showed potent down-regulation of T cell activation genes, including CD3, CD28, and CXCR4, similar to HDAC inhibitors, but JQ1 also showed potent up-regulation of chromatin modification genes, including SIRT1, HDAC6, and multiple lysine demethylases (KDMs). Thus, JQ1 reactivates HIV-1 while suppressing T cell activation genes and up-regulating histone modification genes predicted to favor increased Tat activity. Thus, JQ1 may be useful in studies of potentially novel mechanisms for transcriptional control as well as in translational efforts to identify therapeutic molecules to achieve viral eradication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · cited 5×
“, bromodomains, with highest specificity for BRD4 and lower specificity for Brd2 and Brd3 [31].”
BackgroundResultSelf-citationIdentification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Self-citationModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186 · cited 2×
“tating lifelong treatment [1–8].”
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050 · cited 1×
“In landmark studies [8–10],”
Identifying biological themes within lists of genes with EASE
Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-10-r70 · Cited by 1,950
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,110
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
Jordan, A., Bisgrove, D., & Verdin, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg188 · Cited by 914
Cytokine-Induced Expression of HIV-1 in a Chronically Infected Promonocyte Cell Line
Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A., & Fauci, A. S. (1987) · Science · doi:10.1126/science.3313729 · Cited by 905
The Challenge of Finding a Cure for HIV Infection
Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 846
Self-citationWeinberger, L. S., Burnett, J. C., Toettcher, J. E., Arkin, A. P., & Schaffer, D. V. (2005) · Cell · doi:10.1016/j.cell.2005.06.006 · Cited by 630
Palmer, S., Wiegand, A. P., Maldarelli, F., Bazmi, H., Mican, J. M., Polis, M., Dewar, R. L., Planta, A., Liu, S., Metcalf, J. A., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4531-4536.2003 · Cited by 604
Van Lint, C., Emiliani, S., Ott, M., & Verdin, E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00449.x · Cited by 580
Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA
Huang, B., Yang, X.-D., Zhou, M.-M., Ozato, K., & Chen, L.-F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01365-08 · Cited by 579
Peart, M. J., Smyth, G. K., van Laar, R. K., Bowtell, D. D., Richon, V. M., Marks, P. A., Holloway, A. J., & Johnstone, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500369102 · Cited by 539
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
Self-citationLeoni, F., Zaliani, A., Bertolini, G., Porro, G., Pagani, P., Pozzi, P., Donà, G., Fossati, G., Sozzani, S., Azam, T., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052702999 · Cited by 508
Dornadula, G. (1999) · JAMA · doi:10.1001/jama.282.17.1627 · Cited by 463
NF‐κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
Williams, S. A., Chen, L., Kwon, H., Ruiz‐Jarabo, C. M., Verdin, E., & Greene, W. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600900 · Cited by 430
Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART
Nettles, R. E. (2005) · JAMA · doi:10.1001/jama.293.7.817 · Cited by 395
Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription
Bisgrove, D. A., Mahmoudi, T., Henklein, P., & Verdin, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705053104 · Cited by 387
Fujinaga, K., Irwin, D., Huang, Y., Taube, R., Kurosu, T., & Peterlin, B. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.787-795.2004 · Cited by 371
Coull, J. J., Romerio, F., Sun, J.-M., Volker, J. L., Galvin, K. M., Davie, J. R., Shi, Y., Hansen, U., & Margolis, D. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.6790-6799.2000 · Cited by 346
Self-citationInduction of HIV-1 latency and reactivation in primary memory CD4+ T cells
Bosque, A., & Planelles, V. (2009) · Blood · doi:10.1182/blood-2008-07-168393 · Cited by 340
ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
Maldarelli, F., Palmer, S., King, M. S., Wiegand, A., Polis, M. A., Mican, J., Kovacs, J. A., Davey, R. T., Rock-Kress, D., Dewar, R., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030046 · Cited by 333
SIRT1 Regulates HIV Transcription via Tat Deacetylation
Pagans, S., Pedal, A., North, B. J., Kaehlcke, K., Marshall, B. L., Dorr, A., Hetzer-Egger, C., Henklein, P., Frye, R., McBurney, M. W., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030041 · Cited by 331
Binding of the 7SK snRNA turns the HEXIM1 protein into a P‐TEFb (CDK9/cyclin T) inhibitor
Michels, A. A., Fraldi, A., Li, Q., Adamson, T. E., Bonnet, F., Nguyen, V. T., Sedore, S. C., Price, J. P., Price, D. H., Lania, L., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600275 · Cited by 303
The Control of HIV Transcription: Keeping RNA Polymerase II on Track
Ott, M., Geyer, M., & Zhou, Q. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.11.002 · Cited by 286
HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
Trono, D., Van Lint, C., Rouzioux, C., Verdin, E., Barré-Sinoussi, F., Chun, T.-W., & Chomont, N. (2010) · Science · doi:10.1126/science.1191047 · Cited by 281
Ylisastigui, L., Archin, N. M., Lehrman, G., Bosch, R. J., & Margolis, D. M. (2004) · AIDS · doi:10.1097/00002030-200405210-00003 · Cited by 254
Self-citationTyagi, M., Pearson, R. J., & Karn, J. (2010) · Journal of Virology · doi:10.1128/jvi.01519-09 · Cited by 249
Prins, J. M., Jurriaans, S., van Praag, R. M. E., Blaak, H., van Rij, R., Schellekens, P. T. A., ten Berge, I. J. M., Yong, S.-L., Fox, C. H., Roos, M. T. L., et al. (1999) · AIDS · doi:10.1097/00002030-199912030-00012 · Cited by 237
The Bromodomain Protein Brd4 Stimulates G1 Gene Transcription and Promotes Progression to S Phase
Mochizuki, K., Nishiyama, A., Jang, M. K., Dey, A., Ghosh, A., Tamura, T., Natsume, H., Yao, H., & Ozato, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707603200 · Cited by 229
Jiang, G., Espeseth, A., Hazuda, D. J., & Margolis, D. M. (2007) · Journal of Virology · doi:10.1128/jvi.01208-07 · Cited by 218
Self-citationExperimental approaches to the study of HIV-1 latency
Han, Y., Wind-Rotolo, M., Yang, H.-C., Siliciano, J. D., & Siliciano, R. F. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1580 · Cited by 208
Hermankova, M., Siliciano, J. D., Zhou, Y., Monie, D., Chadwick, K., Margolick, J. B., Quinn, T. C., & Siliciano, R. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7383-7392.2003 · Cited by 187
Archin, N. M., Eron, J. J., Palmer, S., Hartmann-Duff, A., Martinson, J. A., Wiegand, A., Bandarenko, N., Schmitz, J. L., Bosch, R. J., Landay, A. L., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282fd6df4 · Cited by 186
Self-citationStability of the Latent Reservoir for HIV‐1 in Patients Receiving Valproic Acid
Siliciano, J. D., Lai, J., Callender, M., Pitt, E., Zhang, H., Margolick, J. B., Gallant, J. E., Cofrancesco, Jr., Moore, R. D., Gange, S. J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/511823 · Cited by 182
A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load
Malnati, M. S., Scarlatti, G., Gatto, F., Salvatori, F., Cassina, G., Rutigliano, T., Volpi, R., & Lusso, P. (2008) · Nature Protocols · doi:10.1038/nprot.2008.108 · Cited by 167
Archin, N. M., Cheema, M., Parker, D., Wiegand, A. P., Bosch, R. J., Coffin, J. M., Eron, J. J., Cohen, M. S., & Margolis, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009390 · Cited by 160
Self-citationProlonged valproic acid treatment does not reduce the size of latent HIV reservoir
Lerolle, N., Lamine, A., Chaix, M., Boufassa, F., Aboulker, J.-P., Costagliola, D. G., Goujard, C., Paller, C., Delfraissy, J., & Lambotte, O. (2008) · AIDS · doi:10.1097/qad.0b013e3282fd6ddc · Cited by 158
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses
Moreira, J. M. A., Scheipers, P., & Sørensen, P. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-30 · Cited by 144
van Praag, R. M. E., Prins, J. M., Roos, M. T. L., Schellekens, P. T. A., ten Berge, I. J. M., Yong, S. L., Schuitemaker, H., Eerenberg, A. J. M., Jurriaans, S., de Wolf, F., et al. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1011091300321 · Cited by 140
Williams, S. A., Kwon, H., Chen, L., & Greene, W. C. (2007) · Journal of Virology · doi:10.1128/jvi.02074-06 · Cited by 139
Zhang, Z., Klatt, A., Gilmour, D. S., & Henderson, A. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610688200 · Cited by 123
Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir
Matalon, S., Rasmussen, T. A., & Dinarello, C. A. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00076 · Cited by 121
Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency
Duverger, A. E., Jones, J., May, J. E., Bibollet‐Ruche, F., Wagner, F. A., Cron, R. Q., & Kutsch, O. (2009) · Journal of Virology · doi:10.1128/jvi.02058-08 · Cited by 115
Sakane, N., Kwon, H.-S., Pagans, S., Kaehlcke, K., Mizusawa, Y., Kamada, M., Lassen, K. G., Chan, J., Greene, W. C., Schnoelzer, M., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002184 · Cited by 111
Persaud, D., Siberry, G. K., Ahonkhai, A. A., Kajdas, J., Monie, D., Hutton, N., Watson, D. C., Quinn, T. C., Ray, S. C., & Siliciano, R. F. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.968-979.2004 · Cited by 111
Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR
Duyne, R. V., Easley, R., Wu, W., Berro, R., Pedati, C., Klase, Z. A., Kehn‐Hall, K., Flynn, E. K., Symer, D. E., & Kashanchi, F. (2008) · Retrovirology · doi:10.1186/1742-4690-5-40 · Cited by 103
Hexamethylbisacetamide and Disruption of Human Immunodeficiency Virus Type 1 Latency in CD4+T Cells
Choudhary, S. K., Archin, N. M., & Margolis, D. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/529525 · Cited by 73
Self-citationEvidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals
Hatano, H., Delwart, E., Norris, P. J., Lee, T., Neilands, T. B., Kelley, C. F., Hunt, P. W., Hoh, R., Linnen, J. M., Martin, J. N., et al. (2010) · AIDS · doi:10.1097/qad.0b013e32833dba03 · Cited by 71
NF-κ B-Dependent and -Independent Pathways of HIV Activation in a Chronically Infected T Cell Line
Antoni, B. A., Rabson, A. B., Kinter, A. L., et al. (1994) · Virology · doi:10.1006/viro.1994.1390 · Cited by 67
Rao, J. N., Neumann, L., Wenzel, S., Schweimer, K., ROSCH, P. J., & Wöhrl, B. M. (2006) · Biochemical Journal · doi:10.1042/bj20060421 · Cited by 47
Pharmaceutical approaches to eradication of persistent HIV infection
Bowman, M. C., Archin, N. M., & Margolis, D. M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000970 · Cited by 37
Self-citation
Cited by
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Shi, J., & Vakoc, C. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.016 · Cited by 878
Protein Lysine Acetylation by p300/CBP
Dancy, B. M., & Cole, P. A. (2015) · Chemical Reviews · doi:10.1021/cr500452k · Cited by 609
Bullen, C. K., Laird, G. M., Durand, C. M., Siliciano, J. D., & Siliciano, R. F. (2014) · Nature Medicine · doi:10.1038/nm.3489 · Cited by 488
BET Proteins as Targets for Anticancer Treatment
Stathis, A., & Bertoni, F. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0605 · Cited by 463
“Although this can be therapeutically exploited to eliminate latent viral infections (76, 77, 82), it advises for a close monitoring of patients with cancer receiving BET inhibitors for reactivation of viral infections.”
BackgroundBET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
Anand, P., Brown, J. D., Lin, C. Y., Qi, J., Zhang, R., Artero, P. C., Alaiti, M. A., Bullard, J., Alazem, K., Margulies, K. B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.013 · Cited by 406
“, 2010), HIV infection (Banerjee et al., 2012), and spermatogenesis (Matzuk et al.”
Self-citation
Metadata
- Authors
- Banerjee, C., Archin, N., Michaels, D., Belkina, A. C., Denis, G. V., Bradner, J., Sebastiani, P., Margolis, D. M., & Montano, M.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-01
- Volume
- 92
- Issue
- 6
- Pages
- 1147-1154
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2160076049
- Cited by
- 256
- References
- 56
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.